Detecting Changes in Arterial Blood Volume and Cardiac Efficiency

HemoCept Inc.

Status: Enrolling

Conditions: Aortic Valve Stenosis

Study type: Observational

Funder types: Industry

Identifiers

NCT07205341

PRT-012

Details and patient eligibility

About

The objective of this Pilot Study is to demonstrate the efficacy of the Hemocept device in detecting changes in arterial blood volume and cardiac efficiency.

Enrollment: 20 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures.

• Subjects can be any gender but must be between (and including) the ages of 18 and 80.

• Subject ls being treated by the participating healthcare facility .

  ., Subject requires a trans-aortic valve replacement.

• Subject is able and willing to provide informed consent and HIPM authorization.

• Subject is able and willing to meet all study requirements.

Exclusion criteria

• Subject is pregnant, breast-feeding, or intends to become pregnant during the course of the study.

• Subject has a personal medical history that includes:

  • Long O-T syndrome
  • Cardiac channelopathies
  • Seizures